Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

370.45

372.49

-2.04

-0.55%

Other Operating Income

0.00

Total Operating income

370.45

372.49

-2.04

-0.55%

Raw Material Cost

85.19

156.16

-70.97

-45.45%

Purchase of Finished goods

22.31

18.21

4.10

22.52%

(Increase) / Decrease In Stocks

-14.63

-4.04

-10.59

-262.13%

Employee Cost

50.86

57.45

-6.59

-11.47%

Power Cost

0.00

Manufacturing Expenses

0.00

1.65

-1.65

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

91.13

80.37

10.76

13.39%

Total Expenditure (Excl Depreciation)

234.86

309.80

-74.94

-24.19%

Operating Profit (PBDIT) excl Other Income

135.59

62.69

72.90

116.29%

Other Income

4.00

19.75

-15.75

-79.75%

Operating Profit (PBDIT)

139.59

82.44

57.15

69.32%

Interest

0.21

2.53

-2.32

-91.70%

Exceptional Items

0.00

Gross Profit (PBDT)

139.38

79.91

59.47

74.42%

Depreciation

6.17

31.16

-24.99

-80.20%

Profit Before Tax

133.21

48.75

84.46

173.25%

Tax

38.61

12.94

25.67

198.38%

Provisions and contingencies

0.00

Profit After Tax

94.60

35.81

58.79

164.17%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

94.60

35.81

58.79

164.17%

Equity Capital

16.60

87.37

-70.77

-81.00%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

56.99

0.82

56.17

6,850.00%

Diluted Earnings per share

56.99

0.81

56.18

6,935.80%

Operating Profit Margin (Excl OI)

36.60%

16.83%

0.00

19.77%

Gross Profit Margin

37.62%

21.45%

0.00

16.17%

PAT Margin

25.54%

9.61%

0.00

15.93%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 370.45 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -0.91% vs 15.06% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 94.60 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 21.92% vs -12.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 135.59 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 22.75% vs -8.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Quarterly - Interest

Interest 0.21 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 110.00% vs -16.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 36.60%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025